ArticleClinical epigenetics2025

The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells.

Anjali Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.